VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PRAProAssurance Corporation
$25.00$1.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksPRACash Flow

ProAssurance Corporation (PRA) Cash Flow Statement

30Y historyFree accessUpdated daily

Liquidity remains under pressure as quarterly claims payments frequently exceed $200 million, forcing the firm to rely on active investment portfolio turnover to manage cash flow requirements.

PRA Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations-14.01M-25.62M-10.71M-49.88M-29.84M73.97M92.34M148.17M177.26M173.39M178.98M111.12M96M38.6M91.25M159.36M139.19M75.41M164.78M244.11M182.83M323.59M373.54M282.8M176.96M61.26M36.34M46.4M71M43.2M74.8M
Operating CF Growth %-5347.13%-139.1%78.52%-67.17%-140.34%-19.9%-37.68%-16.42%2.24%-3.13%61.07%15.75%148.7%-57.7%-42.74%14.49%84.58%-54.24%-32.5%33.52%-43.5%-13.37%32.09%59.81%188.86%68.6%-21.69%-34.65%64.35%-42.25%58.47%
Operating CF / Revenue %-1.3%-2.33%-0.95%-4.41%-2.71%6.88%10.41%14.67%20.21%20.21%20.43%14.46%11.32%5.27%12.63%21.95%20.11%11.21%29.29%34.57%24.79%49.94%47.01%52.78%44.01%16.01%16.32%22.29%36.67%26.88%53.7%
Net Income65.2M50.91M52.74M-38.6M-402K144.12M-175.73M1M47.06M107.26M151.08M116.2M196.56M297.52M275.47M287.1M231.6M222.03M177.72M168.19M126.98M80.03M72.81M38.7M12.21M12.45M24.3M46.7M48.5M37.5M31.1M
Depreciation & Amortization9.87M13.69M17.75M26.02M38.06M37.25M21.38M18.66M21.25M28.8M32.79M36.22M39.59M35.83M37.57M35.69M26.67M19.66M16.57M16.09M18.83M24M24.84M23.51M15.04M3.24M6.33M6.4M3.2M3M200K
Stock-Based Compensation6.06M7.85M6.2M5.25M4.83M4.39M3.84M3.53M5.32M10.62M12.46M9.17M10.06M9.24M8.64M7.12M6.14M6.21M7.76M8.33M00000000000
Deferred Taxes16.78M16.79M12.82M-1.77M-6.62M1.32M-21.15M-28.64M-11.82M08.53M-15.99M6.79M24.66M37.74M-1.05M-4.4M26.61M-233K3.82M1.39M707K1.11M93K87K1.72M854K2.3M7.7M-700K-1.7M
Other Non-Cash Items12.24M11.27M-4.28M41.17M58.79M-126.01M203.07M-25.26M61.09M-3.68M-21.91M30.79M-25.41M-118.25M-27.77M-4.52M-27.31M-18.04M50.43M43.54M-99.21M-4.91M-12.54M-227.01M-97.21M9.87M-5.96M13.2M118.7M43.9M-88.2M
Working Capital Changes-115.69M-126.13M-95.96M-81.94M-124.5M12.9M60.93M178.87M54.37M30.39M-3.97M-65.26M-131.6M-210.4M-240.41M-164.97M-93.51M-181.06M-87.48M4.15M134.84M223.77M287.32M447.51M246.83M33.98M10.8M-22.2M-107.1M-40.5M133.4M
Cash from Investing15.33M19.44M10.67M141.14M-62M-85.53M-8.48M50.52M214.9M200.28M-278.94M227.79M266.98M-67.8M26.84M-49.61M-22.35M20.84M-91.57M-166.46M-189.65M-313.43M-430.44M-379.66M-122.61M-98.92M-37.64M-8.1M-65.4M-43.3M-65M
Capital Expenditures-2.87M-3.6M-9.02M-4.79M-4.35M-3.84M-7.48M-9.59M-9.64M0-10.92M-9.52M5.43M-5.85M0000000000000000-7.3M
Acquisitions-924K19.38M39.68M0000216.7M-70.82M-42.69M0-73.92M0-52.67M00-251.33M-127.05M-25.75M-15.81M00000000000
Purchase of Investments-132.22M-924.07M-798.44M-464.94M-681.25M-1.51B0-770.19M-1.05B-915.35M-767.9M-885.55M-850.99M-817.56M-822.1M-904.43M-869.74M-964.04M-953.01M-1.43B-2.41B-903.64M-1.2B-1.15B-1.04B-677.7M-184M-193.8M-390.9M-227.5M-195.5M
Sale/Maturity of Investments129.95M907.45M778.45M586.17M656.2M1.35B0597.59M1.07B1.11B530.05M1.17B998.19M920.82M1.04B893.8M1.04B1.11B908.77M1.29B2.33B642.25M755.6M1.3B920.88M706.5M154.76M179.4M325.7M184.4M135.2M
Other Investing21.39M20.27M024.69M-32.59M78.31M-1.01M16M282.18M50.35M-30.17M27.85M114.36M-112.55M-186.55M-38.98M61.81M316K-21.58M-5.59M-106.23M-52.03M16.01M-522.83M-2.79M-127.72M-8.4M6.3M-200K-200K2.6M
Cash from Financing-13.87M-12.2M-10.97M-55.31M-21.8M-60.62M-43.45M-103.79M-446.19M-356.51M-13.93M-294.85M-295.32M40.03M-129.94M-30.2M-106.64M-59.07M-100.02M-67.71M1.46M3.64M44.94M682K35.79M82.27M-9.56M-28M-8.8M-1.7M0
Dividends Paid000-5.38M-10.77M-10.76M-38.66M-93.2M-316.48M-315.23M-118.81M-217.63M-71.25M-46.38M-200.12M-7.62M000000000000-100K-100K0
Share Repurchases-1.2M00-50.49M-3.25M-10.38M-2.35M0-1M0-2.11M-172.77M-222.36M-29.09M0-20.57M-106.35M-52.05M-87.56M-54.2M00000-1.34M-9.56M-27.9M-8.7M-1.6M0
Stock Issued008K0010.38M2.35M0000000000000000046.5M000000
Debt Issuance (Net)-3M-1000K-1000K00-1000K-1000K-1000K-1000K-1000K1000K1000K01000K1000K-325K-303K-1000K-1000K-1000K001000K1000K-1000K1000K00000
Other Financing-7.98M-5.95M-6.29M552K-7.79M-3.38M-935K-9.14M-5.31M-4.75M6.98M-4.45M-1.71M-7.32M2.84M-1.69M14K-24K18.47M1.96M1.46M3.64M35K-31.46M-707K1.11M0-100K000
Net Change in Cash-29.49M-18.39M-11.02M35.94M-113.64M-72.18M40.41M94.9M-54.02M17.15M-123.75M44.06M67.66M10.83M-11.85M79.55M10.21M37.18M-26.82M9.94M-5.36M13.81M-11.96M-96.17M90.14M44.61M-10.86M10.4M-3.2M-1.7M9.8M
Exchange Rate Effect000000000000000000000000000100K000
Cash at Beginning36.49M54.88M65.9M29.96M143.6M215.78M175.37M80.47M134.5M117.35M241.1M197.04M129.38M118.55M130.4M50.85M40.64M3.46M30.27M29.15M34.51M20.7M42.05M143.31M53.16M8.55M19.41M9M12.2M14M4.2M
Cash at End14.05M36.49M54.88M65.9M29.96M143.6M215.78M175.37M80.47M134.5M117.35M241.1M197.04M129.38M118.55M130.4M50.85M40.64M3.46M39.09M29.15M34.51M30.08M47.13M143.31M53.16M8.55M19.4M9M12.3M14M
Free Cash Flow-16.88M-29.22M-19.73M-54.67M-34.19M70.13M84.86M138.58M167.63M162.9M168.06M101.6M93.12M32.76M91.25M159.36M139.19M75.41M164.78M244.11M182.83M323.59M373.54M282.8M176.96M61.26M36.34M46.4M71M43.2M67.5M
FCF Growth %11.54%-48.08%63.91%-59.9%-148.76%-17.36%-38.76%-17.33%2.9%-3.07%65.41%9.11%184.29%-64.1%-42.74%14.49%84.58%-54.24%-32.5%33.52%-43.5%-13.37%32.09%59.81%188.86%68.6%-21.69%-34.65%64.35%-36%56.98%
FCF Margin %-1.56%-2.66%-1.75%-4.84%-3.1%6.52%9.57%13.72%19.11%18.98%19.19%13.22%10.98%4.47%12.63%21.95%20.11%11.21%29.29%34.57%24.79%49.94%47.01%52.78%44.01%16.01%16.32%22.29%36.67%26.88%48.46%
FCF per Share-0.33-0.57-0.38-1.04-0.631.31.572.573.123.043.141.851.560.531.482.582.161.142.43.412.624.925.844.653.371.260.780.971.440.871.4

Key Metrics

Growth RegimeContracting
ProfitabilityStrained
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Reserve volatility and social inflation

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Underwriting Cash Generation Remains Volatile

Based on the provided quarterly cash flow data, ProAssurance exhibits significant volatility in underwriting cash generation, with operating cash flow fluctuating between a $28.1 million outflow in 2025Q2 and a $27.2 million inflow in 2025Q3, reflecting the inherent unpredictability of long-tail medical professional liability claims payments.

The frequent swings between positive and negative operating cash flow suggest that the company's core underwriting operations are struggling to maintain a consistent float-generating profile. This instability appears to be driven by the timing of large claim settlements, which often overwhelm premium inflows in any given quarter.

Investment Portfolio Liquidity Supports Operations

As reported in the company's financial statements, ProAssurance maintains a highly active investment portfolio, with quarterly purchases and sales frequently exceeding $200 million, indicating that the firm relies heavily on portfolio turnover to manage liquidity needs when underwriting cash flows fail to cover immediate claim obligations.

The high volume of investment activity relative to the company's market capitalization suggests that management is actively recycling capital to optimize yield and meet liquidity requirements. Investors should monitor whether this reliance on portfolio liquidation to fund operations may eventually constrain the company's ability to benefit from long-term compounding in a higher interest rate environment.

Claims Payment Lags Pressure Liquidity

According to the historical data, ProAssurance consistently processes quarterly claims payments exceeding $200 million, a figure that frequently dwarfs net income and underscores the intense liquidity pressure inherent in the medical professional liability sector where long-tail claims create persistent, multi-year cash outflows for the firm.

The magnitude of these claims payments relative to net income highlights the company's vulnerability to adverse loss development. If social inflation continues to drive up the severity of these settlements, the company may find its cash reserves increasingly strained, necessitating more frequent and potentially disadvantageous liquidations of its fixed-income portfolio.

Statutory Earnings Diverge From Cash

Based on the reported figures, there is a notable disconnect between net income and operating cash flow, exemplified by the 2025Q3 period where the company reported $1.4 million in net income while generating $27.2 million in operating cash, suggesting significant non-cash accruals and reserve adjustments.

This divergence implies that headline earnings may not be a reliable proxy for the company's actual cash-generating capacity. Analysts should interpret these discrepancies as a potential signal that reserve releases or other accounting adjustments are masking the underlying cash-flow challenges faced by the specialty insurance segments.

PRA — Frequently Asked Questions

Quick answers to the most common questions about buying PRA stock.

How much cash does ProAssurance Corporation (PRA) generate from operations?

ProAssurance Corporation (PRA) generated $-25.6M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is ProAssurance Corporation's free cash flow?

ProAssurance Corporation (PRA) reported negative free cash flow of $29.2M in 2025, indicating capital requirements exceeded cash from operations.

What is ProAssurance Corporation's capital expenditure (CapEx)?

ProAssurance Corporation (PRA) spent $3.6M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.